Valuation: Guerbet

Market Cap 111M 127M 104M 95.18M 178M 12.24B 182M 1.24B 482M 6B 476M 465M 20.76B P/E 2026 *
-248x
P/E 2027 * 5.49x
Enterprise Value 405M 461M 376M 346M 649M 44.5B 661M 4.49B 1.75B 21.81B 1.73B 1.69B 75.47B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.49x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.96%
1 day-0.67%
1 week+0.34%
Current month-2.43%
1 month-2.97%
3 months-11.17%
6 months-36.01%
Current year-38.25%
1 week 8.7
Extreme 8.7
9.28
1 month 8.6
Extreme 8.6
9.65
Current year 8.01
Extreme 8.01
15.12
1 year 8.01
Extreme 8.01
23.4
3 years 8.01
Extreme 8.01
40.25
5 years 8.01
Extreme 8.01
45.65
10 years 8.01
Extreme 8.01
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 49 19/05/2017
Director/Board Member 51 22/11/2023
Date Insider Type Main position Quantity % Market Cap.
13/11/25 Buy

Director

90 0.0007%
13/11/25 Buy

Director

1,100 0.0087%
10/10/25 Buy

Director

200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%+0.34%-58.93%-54.58% 128M
+0.01%+4.45%-14.78%-16.59% 13.79B
+1.52%-8.34%+40.09%-8.60% 3.89B
-0.23%+0.26%+66.71%+103.29% 1.2B
-3.05%-2.34%-38.13%-60.52% 1.21B
+0.19%-2.78%-41.32%-47.39% 1.09B
+0.34%+2.35%-42.93% - 934M
+2.37%-14.11%+49.28%+79.71% 457M
-4.49%+4.27%+50.00% - 345M
-0.21%+0.88%-58.49%+234.80% 262M
Average -0.42%+1.06%-4.85%+28.77% 2.33B
Weighted average by Cap. +0.08%+2.21%-3.53%-7.81%

Financials

2026 *2027 *
Net sales 754M 858M 700M 644M 1.21B 82.83B 1.23B 8.37B 3.26B 40.6B 3.22B 3.15B 140B 796M 906M 740M 680M 1.28B 87.49B 1.3B 8.84B 3.45B 42.88B 3.4B 3.33B 148B
Net income -1.62M -1.84M -1.5M -1.38M -2.59M -178M -2.64M -17.95M -7M -87.1M -6.9M -6.76M -301M 29.08M 33.09M 27.02M 24.85M 46.58M 3.2B 47.48M 323M 126M 1.57B 124M 121M 5.42B
Net Debt 294M 334M 273M 251M 470M 32.26B 479M 3.26B 1.27B 15.81B 1.25B 1.23B 54.71B 277M 316M 258M 237M 444M 30.48B 453M 3.08B 1.2B 14.94B 1.18B 1.16B 51.7B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
23/07/26 EUR 8.830 -0.67% 5,451
22/07/26 EUR 8.890 +0.68% 14,198
21/07/26 EUR 8.830 +0.80% 11,686
20/07/26 EUR 8.760 -2.23% 15,066
17/07/26 EUR 8.960 +1.13% 15,435
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
8.830EUR
Average target price
11.60EUR
Spread / Average Target
+31.37%

Quarterly revenue - Rate of surprise